Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis
Clinical trial NCT01347190 · COMPLETED
Trial details
- NCT number
- NCT01347190
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2011-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.